RxDoctor Payments Data

Keith Brown, MD

Anatomic Pathology & Clinical Pathology · Flowood, MSNPI 1376710756

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 49.7% of the total. Reporting peaked in 2021 at $288 and has fallen 92.8% since, to $21 in 2025.

$911in general payments, 2019–2025

Across 55 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$452
  • Takeda Pharmaceuticals U.S.A., Inc.$189
  • Astellas Pharma US Inc$70
  • Hologic Sales And Service, LLC$62
  • Pharmacosmos Therapeutics Inc.$31
  • Regeneron Healthcare Solutions, Inc.$21
  • plus $85 from 6 others

What the payments were for

  • Food & beverage$911100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$911 in reported general payments places this provider in the 85th percentile of 69 anatomic pathology & clinical pathology providers in Mississippi.

See all anatomic pathology & clinical pathology providers in Mississippi

Medicare billing

Part B allowed, 2024
$376,136
Medicare patients
2,184
Services billed
6,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →